Latest News
Alvotech and Dr. Reddy's collaborate on biosimilar candidate to cancer drug pembrolizumab
5 June 2025 - Biotechnology company Alvotech SA (NASDAQ:ALVO) and Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. (BSE:500124, NSE:DRREDDY, NYSE:RDY, NSEIFSC:DRREDDY) announced on Thursday that they have entered into a collaboration ...
Mycovia Pharmaceuticals reports first participant enrolled in Phase 2 cryptococcal meningitis study
5 June 2025 - US pharmaceutical company Mycovia Pharmaceuticals Inc announced on Wednesday that the first participant has been enrolled in an investigator-initiated clinical trial evaluating oteseconazole and other investigational products for crypto...
Aitia partners with Gustave Roussy in identifying fundamental biological causes of human cancers
5 June 2025 - Aitia, a US-based company involved in computationally discovering and applying new knowledge of biological causes of disease to pharmaceutical discovery and development, announced on Wednesday a partnership with Gustave Roussy, a cancer...
Innovent's IBI363 granted second breakthrough therapy designation in China
5 June 2025 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Wednesday that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted a second Breakthrough The...
Akeso's cadonilimab gains Chinese approval for first-line treatment of cervical cancer
5 June 2025 - Chinese pharmaceutical company Akeso Inc (HK:9926) announced on Wednesday that China's National Medical Products Administration (NMPA) has approved the company's first- in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, fo...